Lupus nephritis (LN) is a major manifestation of systemic lupus erythematosus (SLE), causing morbidity and mortality in 40-60% of SLE patients. The pathogenic mechanisms of LN are not completely understood. Recent studies have demonstrated the presence of various immune cell populations in lupus nephritic kidneys of both SLE patients and lupusprone mice. These cells may play important pathogenic or regulatory roles in situ to promote or sustain LN. Here, using lupus-prone mouse models, we showed the pathogenic role of a kidney-infiltrating CD11c
Summary
Lupus nephritis (LN) is a major manifestation of systemic lupus erythematosus (SLE), causing morbidity and mortality in 40-60% of SLE patients. The pathogenic mechanisms of LN are not completely understood. Recent studies have demonstrated the presence of various immune cell populations in lupus nephritic kidneys of both SLE patients and lupusprone mice. These cells may play important pathogenic or regulatory roles in situ to promote or sustain LN. Here, using lupus-prone mouse models, we showed the pathogenic role of a kidney-infiltrating CD11c
1 myeloid cell population in LN. These CD11c 1 cells accumulated in the kidneys of lupusprone mice as LN progressed. Surface markers of this population suggest their dendritic cell identity and differentiation from lymphocyte antigen 6 complex (Ly6C) low mature monocytes. The cytokine/chemokine profile of these renal-infiltrating CD11c 1 cells suggests their roles in promoting LN, which was confirmed further in a loss-of-function in-vivo study by using an antibody-drug conjugate (ADC) strategy targeting CX 3 CR1, a chemokine receptor expressed highly on these CD11c 1 cells. However, CX 3 CR1 was dispensable for the homing of CD11c 1 cells into lupus nephritic kidneys.
Finally, we found that these CD11c 1 cells co-localized with infiltrating T cells in the kidney. Using an ex-vivo co-culture system, we showed that renal-infiltrating CD11c 1 cells promoted the survival, proliferation and interferon-g production of renal-infiltrating CD4 1 T cells, suggesting a T cell-dependent mechanism by which these CD11c 1 cells promote LN.
Introduction
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease induced by the breach of systemic immunotolerance to self-antigens that are typically nuclear components and phospholipids [1, 2] . It manifests as persistent inflammation in multiple organs, including kidney, lung, skin, heart, joints and brain [3] . Among different manifestations, lupus nephritis (LN; inflammation of the kidney), occurs in approximately 50% of SLE patients and is a major cause of morbidity and mortality in SLE patients [4] . Commonly used anti-inflammatory and immunosuppressive chemical drugs have prolonged the survival of patients with LN significantly [3] , but systemic side effects are a major cause of concern. Recently, several antibodybased products aimed to perturb specific immune reactions have been developed and evaluated in clinical trials to reduce or replace the use of chemical drugs [3, 5, 6] . However, these treatments are not so specific for autoimmune reactions that they can compromise the normal immune response to infections [7, 8] . In addition, some LN patients are resistant to current standard-of-care treatments or experience relapses of symptoms [9] . Therefore, it is urgent and necessary to continue investigating the kidney-specific immune mechanisms behind LN, which may lead to the development of more effective drugs with fewer side effects. LN is known to be initiated by renal deposition of highaffinity autoantibodies generated by activated autoreactive B cells with the help from activated autoreactive T cells [3, 10] . However, the downstream immune mechanisms causing the progression of LN are not well understood. Studies have shown that different types of leucocytes, including various T cell subsets, B cells, plasma cells, natural killer cells, monocytes/macrophages, dendritic cells (DCs) and neutrophils, are accumulated in the kidneys of both patients and lupus-prone mice with active LN [11, 12] . Using lupus-prone mice, one study demonstrated further that LN could still develop in the absence of humoral immune responses, and such development was associated with leucocyte infiltrations in the kidney [13] . This highlights the critical roles of cellular immune responses in LN progression.
Among different renal-infiltrating cell types, DCs are of interest because there are many subtypes of DCs, and each of them has specific and diverse immune functions through interacting with other immune cells [14] . As a general surface marker for DCs, CD11c has been utilized in lupusprone mice to demonstrate the pathogenic roles of CD11c 1 cells in SLE, particularly in the development of LN [15] [16] [17] [18] [19] [20] . However, as CD11c is also expressed on some macrophages [14] , it is unclear whether the pathogenic CD11c 1 cells belong to DCs, and if they do, which subpopulation(s) of DCs are more important for LN progression. Plasmacytoid DCs (pDCs), a subpopulation of DCs, have been demonstrated to be critical in initiating autoimmune responses in SLE by producing interferon (IFN)-a [17, 18] . Unlike pDCs, the role of conventional DCs (cDCs) subsets in LN remains unclear. The aim of this study was to reveal the pathogenic roles of cDCs in the development of LN. Here, using lupus-prone mice, we show that a subpopulation of CD11c 1 cells with surface markers representing mature monocyte-derived cDCs accumulates in lupus nephritic kidneys, and has a pathogenic role in promoting LN, at least partially, by enhancing kidney-infiltrating T cell responses.
Materials and methods

Mice
Murphy Roths large (MRL)/Mp (MRL), MRL/Mp-Fas lpr (MRL/lpr), New Zealand white (NZW)/Lac (NZW), NZBWF 1 (NZB/W) and B6-CX 3 CR1
gfp/gfp mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA) and maintained in a specific pathogen-free facility following the requirements of Institutional Animal Care and Use Committee (IACUC) at Virginia Polytechnic Institute and State University. MRL and MRL/lpr are classical mouse models of LN. Mice with an MRL background possess multiple SLE susceptibility loci and exhibit autoimmune disorders similar to SLE-associated manifestations in humans. With the spontaneous mutation Fas lpr , MRL/ lpr mice show lymphadenopathy and glomerulonephritis early in life. Female MRL/lpr mice die at an average age of 16 weeks. These mice develop severe kidney disease, with proteinuria detectable starting at 8 weeks of age. In contrast, the parent and control strain (MRL) does not show any sign of kidney disease before 18 weeks of age. Nevertheless, the MRL mouse is another lupus-prone mouse model that develops kidney disease at approximately 9 months of age. Like MRL and MRL/lpr mice, NZB/W mice display high levels of anti-nuclear antibodies, proteinuria and glomerulonephritis. The time-course of LN in NZB/W mice is similar to that in MRL mice.
Leucocyte isolation
For kidney leucocytes, kidneys were cut into 1-2 mm 3 pieces and digested in 5 ml digestion buffer [10% fetal bovine serum (FBS), 10 mM HEPES, 1 mg/ml collagenase D (Sigma-Aldrich, St Louis, MO, USA) and 0Á2 mg/ml DNase I (Sigma-Aldrich) in RPMI-1640 medium] for 30 min at 378C with gentle shaking. Ice-cold 31 phosphatebuffered saline (PBS, 10 ml) containing 10 mM ethylenediamine tetraacetic acid (EDTA) was added, followed by another 5 min of incubation on ice. After being vortexed several times, tissue pieces were filtered, smashed and washed twice with wash buffer [0Á1% bovine serum albumin (BSA), 5 mM EDTA and 10 mM Hepes in 31 Hanks's balanced salt solution (HBSS) without Ca 21 and Mg
21
, all from Life Technologies, Grand Island, NY, USA] through 70-lm cell strainers. The flow-through solution containing cells was then centrifuged. The cell pellet was resuspended in 10 ml 37% stock isotonic Percoll (SIP) solution (100% SIP was made by mixing 9 vols Percoll with 1 vol 310 PBS; then the 100% SIP was diluted with wash buffer to make 70% SIP and 37% SIP) and layered carefully on top of 5 ml 70% SIP. After 30 min continuous centrifugation at 1000 g at room temperature, enriched leucocytes were collected from the layer between 37 and 70% SIP. For bone marrow mononuclear cells, bones from both hind limbs of each mouse were cracked gently in a mortar containing PBS using a pestle. Bone marrow was released by gentle stirring after the addition of C10 medium [RPMI-1640, 10% FBS, 1 mM sodium pyruvate, 1% 3100 minimum essential medium (MEM) non-essential amino acids, 10 mM HEPES, 55 lM 2-mercaptoethanol, 2 mM L-glutamine, 100 U/ml penicillin-streptomycin, all from Life Technologies]. The suspension was cleared by passing through a 70-lm sterile cell strainer and layered carefully on top of Ficoll-Paque Plus (GE Healthcare, Pittsburg, PA, USA). After 30 min continuous centrifugation at 1363 g at room temperature, mononuclear cells in the buffy coat layer were collected. For direct flow cytometry detection, spleens and all lymph nodes in the mesenteric region (MLN) were collected and mashed in 70-lm cell strainers with C10. For purification of splenic CD8 1 cDCs, spleens were injected with 500 ll digestion buffer (as used in kidney digestion), cut into 1-2 mm 3 pieces and digested in 5 ml digestion buffer for 30 min at 378C with gentle shaking. Ice-cold 31 PBS containing 10 mM EDTA was added, followed by another 5 min of incubation on ice. After being pipetted several times, cell suspensions were filtered through a 70-lm cell strainer. The remaining tissue pieces in the cell strainer were smashed and washed. For total splenocytes or purification of CD8
1 DCs from the spleen, red blood cells were lysed with red blood cell (RBC) lysis buffer (eBioscience, San Diego, CA, USA).
In-vivo antibody-drug conjugate (ADC) treatment 
Immunohistochemistry (IHC)
Kidneys were embedded in Tissue-Tek V R OCT TM Compound (Sakura Finetek, Torrance, CA, USA) and frozen rapidly in a freezing bath of dry ice and 2-methylbutane. Frozen OCT samples were cryosectioned and unstained slides were stored at 2808C. Frozen slides were warmed to room temperature and allowed to dry for 30 min, followed by fixation in 2208C cold acetone at room temperature for 10 min. After washing in PBS, slides were blocked with PBS containing 1% BSA and anti-mouse CD16/32 for 20 min at room temperature. Slides were then incubated with fluorochrome-conjugated antibody mixture for 1 h at room temperature in a dark humid box. Slides were mounted with Prolong Gold containing DAPI (Life Technologies 
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
Bone marrow neutrophils were sorted as DAPI -Ly6G Relative quantities were calculated using L32 as the housekeeping gene. Primer sequences for RT-qPCR can be found in the supplementary materials (Supporting Information, Table S1 ).
Speed congenic back-crossing to generate MRL/lpr-CX 3 CR1-knock-out mice
gfp/gfp mice were bred with MRL/lpr mice to generate F 1 mice. The F 1 generation was intercrossed to generate Fas lpr/lpr CX 3 CR1 gfp/gfp F2 mice determined by the genotyping of Fas and Cx3cr1 genes. Starting from the selected F2 mice, each subsequent generation was backcrossed with MRL/lpr mice and selected by speed congenic strategy [21] plus the Cx3cr1 gene to obtain CX 3 CR1 gfp/1 mice with a maximal MRL/lpr genetic background. The tail tips of the mice were used to extract gDNA by the Quick DNA purification protocol from The Jackson Laboratory. Genotyping of the Fas (wild-type and Fas lpr mutation) and Cx3cr1 genes (wild-type and CX 3 CR1 gfp replacement) was also performed following the protocols from The Jackson Laboratory. Speed congenic PCR was performed by using the following steps: (1) 948C, 3 min; (2) (948C, 20 s; 578C, 15 s, 218C/cycle; 688C, 1 min) 310 cycles; (3) (948C, 15 s; 478C, 15 s; 728C, 1 min) 328 cycles; and (4) 728C, 2 min. KAPA2G Robust HotStart ReadyMix PCR Kit with dye (KAPA Biosystems, Wilmington, MA, USA) was used for the PCR. Primer sequences can be found in the supplementary materials (Supporting Information, Table S2 ). Tail tips of three fifth generation CX 3 CR1
gfp/1 mice were sent to The Jackson Laboratory for single-nucleotide polymorphism screen to determine the purity of the MRL background.
Enzyme-linked immunosorbent assay (ELISA)
Blood was collected into anti-coagulant (potassium EDTA)-coated Capiject tubes (Terumo Medical, Somerset, NJ, USA) and centrifuged at 15 000 g for 30 s. Plasma was collected and stored at 2808C. Detection of anti-doublestranded DNA (dsDNA) IgG was described previously [22] . Total IgG concentrations were determined with mouse IgG ELISA kits, according to the manufacturer's instructions (Bethyl Laboratories, Montgomery, TX, USA).
Proteinuria score and kidney histopathology
Proteinuria was measured weekly with Chemstrip 2GP (Roche, Indianapolis, IN, USA). A scale of 0-3 was used that corresponded to negative-trace (0-20 mg/dl), 30 mg/ dl, 100 mg/dl and ! 500 mg/dl total protein, respectively. Kidneys were fixed in 10% neutral buffered formalin immediately after isolation, paraffin-embedded, sectioned and stained for periodic acid-Schiff (PAS) at the Histopathology Laboratory at Virginia-Maryland College of Veterinary Medicine. Kidney slides were read using the Olympus BX43 microscope. Glomerular lesions were graded on a scale of 0-3 for increased cellularity, increased mesangial matrix, necrosis, percentage of sclerotic glomeruli and presence of crescents [23] . Similarly, tubulointerstitial lesions were graded on a scale of 0-3 for interstitial mononuclear infiltration, tubular damage, interstitial fibrosis and vasculitis. Slides were scored by a board-certified veterinary pathologist (T. E. C.) in a blinded fashion.
Statistical analysis
For the comparison of two groups, the unpaired Student's t-test was used. For the comparison of more than two groups, one-way analysis of variance (ANOVA) and Tukey's post-test were used. Results were considered statistically significant when P < 0Á05. In some experiments, linear regression analysis and Grubbs' test for identification of outliers were used. All analyses were performed with Prism Graphpad software version 5.0b.
Results
Renal accumulation of CD11c
1 myeloid cells as LN progresses (Fig. 1b) , suggesting that they might be of myeloid lineage. The co-expression of CD11c and CD11b was confirmed by IHC staining, with colocalization of CD11c and CD11b signals in the kidney medulla of 4-month-old MRL/lpr mice (Fig. 1c) . Quantification of renal-infiltrating CD11c 1 cells in the kidney of MRL/lpr mice showed a significant increase of the cells from 6 to 15 weeks of age (Fig. 1d) . Using the same gating strategy shown in Fig. 1b infiltration into the kidney of MRL/lpr mice. The migration of leucocytes into specific tissues requires the expression of certain chemokine receptors [27] . As the phenotype of renal-infiltrating CD11c 1 cells suggested that they might be derived from mature monocytes, and that mature monocytes should express a high level of CX 3 CR1 on their surface [26], we measured the expression level of CX 3 CR1 on renal-infiltrating CD11c 1 cells. As expected, these cells expressed CX 3 CR1 highly at both the transcriptional (Fig. 3a) and protein levels (Fig. 3b) . To knock out CX 3 CR1, we performed speed congenic back-crossing of B6-CX 3 CR1
gfp/gfp mice onto the MRL/lpr background by (Fig. 3c) . Unexpectedly, at the age of 15 weeks, the absolute cell number of renalinfiltrating CD11c 1 cells in MRL/lpr-CX 3 CR1 gfp/gfp mice was not significantly different from that in MRL/lpr-CX 3 CR1
1/1 mice, although both of them were higher than that in age-matched MRL control mice (Fig. 3d) . Consistently, nor were the proteinuria scores different between MRL/lpr-CX 3 CR1 gfp/gfp and MRL/lpr-CX 3 CR1 1/1 mice, and both were higher than that of MRL controls (Fig. 3e) ) sorted from the same kidneys of 4-month-old MRL/ lpr mice as determined by RT-qPCR. RL 5 relative level. *P < 0Á05; **P < 0Á01; ***P < 0Á001, one-way analysis of variance (ANOVA). Data are shown as mean 6 standard error of the mean (s.e.m.), n ! 3 mice in each group. [Colour figure can be viewed at wileyonlinelibrary.com] month-old MRL/lpr mice, and found that renal-infiltrating CD11c 1 cells had the highest percentage of CX 3 CR1 1 cells (Fig. 4a) (Fig. 4c ) and could be a target of ADC. Another requirement for successful application of ADC is that target cells should internalize ADC efficiently after antibody binding to the target cells. To study the internalization of CX 3 CR1 after ligation with the anti-CX 3 CR1 antibody, we stained renal-infiltrating CD11c (Fig. 4d) , suggesting efficient internalization of CX 3 CR1 upon antibody ligation. With renal-infiltrating CD11c 1 cells expressing the highest level of CX 3 CR1, and knowing that CX 3 CR1 can be internalized effectively upon ligation with an anti-CX 3 CR1 antibody, we concluded that CX 3 CR1 was a useful target for investigating the role of renal-infiltrating CD11c 1 cells in LN by the ADC method. The ADC we used in vivo was a monoclonal anti-mouse CX 3 CR1-saporin conjugate. In our study, we injected 6 lg ADC intravenously into each MRL/lpr mouse once a week starting from 8 to 15 weeks of age. The same volume of PBS was injected into control MRL/lpr mice. Weekly monitoring of mouse body weight and proteinuria scores revealed that the ADC-treated group had higher body weight and significantly lower proteinuria scores at 15 weeks of age (Fig. 4e) . In addition, linear regression analysis showed that the development of proteinuria was significantly slower in the ADC group than the PBS-treated control group (Fig. 4e) . The histopathological scores (glomerular score and tubulointerstitial score) were lower in the ADC group, but the difference was not statistically Fig. S2c) . No difference was found between the ADC and PBS groups, suggesting that ADC did not affect the systemic autoimmune response, and that its effects were with anti-CD3/CD28, M-CSF and ODN 1585 CpG as determined by enzyme-linked immunosorbent assay (ELISA). *P < 0Á05, **P < 0Á01, ***P < 0Á001, one-way analysis of variance (ANOVA) for (a-f) and Student's t-test for (h-j). Data are shown as mean 6 standard error of the mean (s.e.m.), n 5 3 mice in each group. [Colour figure can be viewed at wileyonlinelibrary.com] kidney-specific. Collectively, these results indicate that ADC administration ameliorated LN in MRL/lpr mice without influencing systemic autoimmune response. As our ADC specifically targeted CX 3 CR1-expressing renalinfiltrating CD11c 1 cells, these results suggest the in-vivo pathogenic role of renal-infiltrating CD11c 1 cells in the development of LN.
Promotion of renal-infiltrating CD4 1 T cell response by syngeneic renal-infiltrating CD11c 1 cells
To study the mechanism by which renal-infiltrating CD11c 1 cells promote LN, we determined their interactions with renal-infiltrating T cells that are known to be pathogenic in LN [29] . Although many renal-infiltrating innate immune cell types, including CD11b -cDCs, monocytes and neutrophils, can interact with T cells, we showed that renal-infiltrating CD11c 1 cells outnumbered significantly the other innate immune cell populations in the kidney of MRL/lpr mice with active LN (15 weeks old) (Fig.  5a ). This suggests that renal-infiltrating CD11c 1 cells may be the predominant innate immune cell type interacting with T cells. Co-staining of the kidney sections of MRL/lpr mice with CD11c and CD3 showed that CD11c 1 cells and T cells localized in the same regions adjacent to each other. In addition, the time-courses of renal infiltration of CD11c 1 cells and T cells were very similar (Fig. 5b) , suggesting that they might interact or facilitate each other's infiltration into the kidney. As shown earlier, the renalinfiltrating CD11c 1 cells possessed the phenotype of DCs (Fig. 2a,b ) that could interact with T cells as typical antigen-presenting cells. We found that these CD11c 1 cells
expressed Fc-gamma-receptor type IV (FcgR-IV) highly and were coated with IgG, in particular pathogenic IgG2a, on their surface (Fig. 5c ), suggesting that they may be able to capture self-antigen in the immune complexes. Moreover, the renal-infiltrating CD11c also expressed higher levels of co-suppressive molecules PD-L1 and PD-L2 (Fig. 5d) . We next performed co-culture experiments between renal-infiltrating CD11c (Fig. 5e ). In addition, upon ex-vivo stimulation with anti-CD3/CD28, CD4 1 T cells were able to produce higher levels of two pathogenic cytokines, IFN-g and IL-17a than CD8
1 and DN T cells (Fig. 5f ). We thus focused our attention on the interaction between CD11c 1 cells and CD4 1 T cells alone (Fig. 5h,i , with representative flow cytometry plots of DAPI and CFSE staining shown in Fig. 5g) . Furthermore, when stimulated with a TLR-9 agonist, renal-infiltrating CD11c 1 cells also enhanced IFN-g production from CD4
1 T cells (Fig. 5j) . Taken together, our results suggest that renal-infiltrating CD11c 1 cells were able to promote the activation of renal-infiltrating CD4
1 T cells, which may be one of the mechanisms by which these CD11c 1 cells deteriorated LN in MRL/lpr mice.
Discussion
CD11c 1 cells have been demonstrated to play pathogenic roles in the development of LN in lupus-prone mice [15, [17] [18] [19] . In addition, the accumulation of CD11c 1 cells has been found in the kidney of both SLE patients and lupus-prone mice with active LN [20, [30] [31] [32] [33] [34] . However, as CD11c 1 cells are extremely heterogeneous, the spatial and temporal roles of different CD11c 1 subsets in LN development have not been well investigated. In this study, we identified a population of DC-like CD11c 1 cells, which accumulated in the kidney of different types of lupusprone mice with active LN. We demonstrated that they were pathogenic in promoting proteinuria through enhancing renal-infiltrating T helper cell responses in the MRL/lpr mouse model. The similar accumulation of CD11c 1 cells in the nephritic kidney of both MRL and MRL/lpr mice suggests that the increase of renalinfiltrating CD11c 1 cells and their pathogenic functions should be due to the multiple SLE susceptibility loci present in the MRL mouse background, rather than the Fas lpr gene mutation in MRL/lpr mice. While the accumulation and subpopulations of renal-infiltrating CD11c 1 cells, especially CD11c
1 CD11b 1 DCs, have also been studied in some other lupus-prone mouse models by other groups [34, 35] [36] . The similar cell population found in NZB/W F 1 mice, however, is negative for CX 3 CR1 expression [34] . This suggests that different lupus-prone mouse models have unique characteristics and our findings in MRL/lpr mice are clinically relevant, as the same population of renal-infiltrating CD11c 1 cells are found in both MRL/lpr mice and SLE patients.
Notably, different from well-accepted concepts that immature monocytes enhance the inflammation whereas mature monocytes down-regulate inflammation [25, 26] , mature monocytes in SLE patients have been suggested to possess a pathogenic role to promote lupus disease by enhancing pathogenic T cell responses [37] . The results of the present study support this notion, as our cell population of interest, which is derived from mature monocytes, appears to be proinflammatory and contributes to disease pathogenesis in LN. Therefore, the functions of a particular cell type may change depending on the microenvironment.
In our study of MRL/lpr mice, renal-infiltrating CD11c 1 cells expressed higher levels of MHC-II and CD86/CD80 co-stimulatory molecules than renal-infiltrating monocytes and neutrophils, suggesting their activated state and ability to activate T helper cells, which was then confirmed by the ex-vivo co-culture experiments. Additionally, later costimulatory molecules, ICOSL and OX40L in particular, also expressed by these renal-infiltrating CD11c 1 cells, have been demonstrated to be pathogenic through activating autoreactive T cells in both lupus-prone mice and SLE patients [15, 16] . However, renal-infiltrating CD11c 1 cells also expressed high levels of co-suppressive molecules PD-L1 and PD-L2. As PD-L1 and PD-L2 are IFN-g-inducible genes that can be up-regulated on IFN-g-activated APCs [38] , this result is consistent with the activated state of renal-infiltrating CD11c 1 cells and suggests their possible interaction with renal-infiltrating T helper cells, in particular IFN-g-producing pathogenic T helper cells. In addition, we found that renal-infiltrating CD4
1 T cells only expressed a low level of PD-1 (data not shown), suggesting a limited suppressive effect of renal-infiltrating CD11c [39] and that the interaction is responsible for the infiltration of pathogenic DCs into the kidney in a nephrotoxic nephritis mouse model [40] . We thus hypothesized that by knocking out CX 3 CR1 from MRL/lpr mice, these renal-infiltrating CD11c 1 cells would be unable to infiltrate into the kidney and LN would be ameliorated. However, these two strategies resulted in different outcomes, with no disease change in CX 3 CR1-knock-out mice but amelioration of LN in ADC-treated mice. This suggests that renal-infiltrating CD11c 1 cells are pathogenic, but their effects may be independent of CX 3 CR1. As the knock-out of CX 3 CR1 failed to prevent their renal accumulation, the infiltration of renalinfiltrating CD11c
1 cells appeared to be CX 3 CR1-independent. This partially explains the unfavourable phenotype in MRL/lpr-CX 3 CR1
-/-mice. To exclude the influence of the remaining B6 genetic background (less than 10%) in the fifth generation of MRL/lpr-CX 3 CR1
-/-mice, we backcrossed the mice further onto an MRL/lpr background for a total of 10 generations that achieved > 99% MRL/lpr genetic purity. Unfortunately, the severity and course of kidney disease were still unaffected (data not shown). Conversely, the ADC method targets renal-infiltrating CD11c 1 cells by directly depleting them or disabling their functions, and is thus a more effective way to demonstrate the in-vivo pathogenic role of renal-infiltrating CD11c 1 cells in LN. The ADC used in this study was designed optimally to maximize its effects. The anti-mouse CX 3 CR1 antibody was of mouse IgG2a origin to reduce host immune responses to ADC. Saporin is a very stable cytotoxic drug that functions by preventing protein synthesis in the cell. It has been used to induce apoptosis of tumour cells in cancer therapies [41] . The potential off-target effect of ADC treatment was a concern, as splenic CD11c 1 CD11b 1 cells expressed the second highest level of CX 3 CR1, but we found that the activated T cells in the spleen and the levels of circulating antibodies including anti-dsDNA antibodies were not different between ADC-and PBS-treated groups. This suggests that ADC treatment did not affect systemic immune responses, and that the pathogenic role of renalinfiltrating CD11c 1 cells might be kidney-specific. The ADC strategy to target renal-infiltrating CD11c 1 cells appears to be efficacious in MRL/lpr mice. This can be highly translatable, where a similar ADC-based drug may be used to target a similar population in LN patients with high efficiency and low side effects. However, further studies are required to characterize these renal-infiltrating CD11c 1 cells in the kidney of LN patients. For example, although the surface markers suggest their mature monocyte origin, this should be confirmed in vivo. In addition, it would be worthwhile to investigate further the molecular mechanisms by which renal-infiltrating CD11c 1 cells promote CD4 1 T cell responses in vivo. Moreover, based on their cytokine/ chemokine profile, it appears that renal-infiltrating CD11c 1 cells may be able to influence renal-infiltrating monocytes [42] , pDCs [43] and B cells [44, 45] 
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